Search - tctmd.com

Displaying 441 - 460 of 1337

Sort: Relevancy | Date

Presentation TVT 2022

Tips and Tricks to Improve Leaflet Coaptation and Imaging During Tricuspid-TEER

Presenter: Philipp Lurz

June 10, 2022

Presentation TVT 2022

Facilitated Tricuspid-TEER With Reverse Trendelenburg: Technique and Outcomes

Presenter: Rebecca T. Hahn

June 10, 2022

Presentation TVT 2022

3D ICE-Guided Tricuspid-TEER: Devices Available and Technique

Presenter: Mackram F. Eleid

June 10, 2022

Presentation TVT 2022

Lessons Learned From Early Generation Transcatheter Annular Reduction Technologies

Presenter: Susheel K. Kodali

June 10, 2022

Presentation TVT 2022

Tricuspid Annular Reduction: Stand-Alone or Adjunctive Therapy?

Presenter: Steven F. Bolling

June 10, 2022

News Conference News TVT 2022

More Support for Single Antiplatelet Therapy After TAVI

Michael O'Riordan

June 10, 2022

Presentation TVT 2022

ViMAC: Clinical Trial Update of TMVR Systems

Presenter: Mayra Guerrero

June 10, 2022

News Conference News TVT 2022

No Stroke Reduction With Embolic Protection in TAVI, Two Studies Suggest

Michael O'Riordan

June 09, 2022

News Conference News TVT 2022

Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests

Michael O'Riordan

June 09, 2022

Presentation TVT 2022

Characteristics of Clinical Trial Sites for Novel Transcatheter Mitral and Tricuspid Valvular Therapies – Inequities in Access to Clinical Trials

Presenter: Ashwin Nathan

June 08, 2022

Presentation TVT 2022

First Report of Outcomes of TEER in Patients With Endocardial Leads: Insights From TRILUMINATE and bRIGHT Clinical Trials

Presenter: Georg Nickenig

June 08, 2022

Presentation TVT 2022

Heterotopic Tricuspid Valve Replacement: Considerations for Future Clinical Trials

Presenter: Ori Ben-Yehuda

June 08, 2022

Presentation TVT 2022

From National Registries to Pragmatic Clinical Trials, From Patient-Reported Outcomes to Shared Decision-making: Not One Size Fits All!

Presenter: Sreekanth Vemulapalli

June 08, 2022

Presentation TVT 2022

Transcatheter versus surgical aortic valve replacement for severe aortic stenosis: a meta-analysis of randomized clinical trials

Presenter: Yousif Ahmad

June 08, 2022

News Daily News

Subclinical Thrombosis After TAVI Benign, at Least to 3 Years

Michael O'Riordan

June 07, 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2022

Shelley Wood

June 01, 2022

News Conference News EuroPCR 2022

Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN

Caitlin E. Cox

May 27, 2022

News Conference News EAS 2022

Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level

Michael O'Riordan

May 24, 2022

News Conference News EuroPCR 2022

Thrombotic vs Bleeding Risks Post-TAVI: Insights From GALILEO

Yael L. Maxwell

May 23, 2022

News Conference News SCAI 2022

SCAI PFO Closure Guideline Addresses Real-world Patient Scenarios

L.A. McKeown

May 20, 2022

Advertisement

Tips and Tricks to Improve Leaflet Coaptation and Imaging During Tricuspid-TEER

Facilitated Tricuspid-TEER With Reverse Trendelenburg: Technique and Outcomes

3D ICE-Guided Tricuspid-TEER: Devices Available and Technique

Lessons Learned From Early Generation Transcatheter Annular Reduction Technologies

Tricuspid Annular Reduction: Stand-Alone or Adjunctive Therapy?

More Support for Single Antiplatelet Therapy After TAVI

ViMAC: Clinical Trial Update of TMVR Systems

No Stroke Reduction With Embolic Protection in TAVI, Two Studies Suggest

Non-COAPT-Like Patients Fare Well With MitraClip, EXPAND Suggests

Characteristics of Clinical Trial Sites for Novel Transcatheter Mitral and Tricuspid Valvular Therapies – Inequities in Access to Clinical Trials

First Report of Outcomes of TEER in Patients With Endocardial Leads: Insights From TRILUMINATE and bRIGHT Clinical Trials

Heterotopic Tricuspid Valve Replacement: Considerations for Future Clinical Trials

From National Registries to Pragmatic Clinical Trials, From Patient-Reported Outcomes to Shared Decision-making: Not One Size Fits All!

Transcatheter versus surgical aortic valve replacement for severe aortic stenosis: a meta-analysis of randomized clinical trials

Subclinical Thrombosis After TAVI Benign, at Least to 3 Years

TCTMD’s Top 10 Most Popular Stories for May 2022

Self-Expanding TAVI Valves Offer Best Results in Small Failed Aortic Bioprostheses: LYTEN

Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level

Thrombotic vs Bleeding Risks Post-TAVI: Insights From GALILEO

SCAI PFO Closure Guideline Addresses Real-world Patient Scenarios

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content